OPTI.C

Optimi Health Corp.

Optimi Health Opens Canada’s Largest GMP-Grade Licensed Psilocybin Cultivation Facility

VANCOUVER, British Columbia, April 28, 2022 -- Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (โ€œOptimiโ€ or the โ€œCompanyโ€), is pleased to announce that it will be inaugurating its recently completed psilocybin cultivation facility with a grand opening event and reception for members of the media, investors and other stakeholders... Read More...

Optimi Health Approved to Supply Psilocybin Under Health Canada’s Special Access Program

Optimi Health Corp.VANCOUVER, British Columbia, Feb. 16, 2022 -- Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (โ€œOptimiโ€ or the โ€œCompanyโ€), developers of a vertically integrated mushroom brand targeting functional and novel psychedelic compounds for the health and wellness sector, is pleased to report that Health Canada has ad... Read More...

Optimi Health Dealer’s License Granted by Health Canada

Optimi Health to become a global leader in all-natural psilocybin productionVANCOUVER, British Columbia, Feb. 07, 2022 -- Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (โ€œOptimiโ€ or the โ€œCompanyโ€), developers of a vertically integrated mushroom brand targeting functional and novel psychedelic compounds for the health and wellne... Read More...